JDM Financial Group’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.6K Hold
3,500
– – ﹤0.01% 212
2026
Q2
$11.9K Hold
3,500
– – ﹤0.01% 197
2026
Q1
$14.6K Hold
3,500
– – 0.01% 164
2025
Q4
$9.6K Hold
3,500
– – ﹤0.01% 188
2025
Q3
$12K Hold
3,500
– – 0.01% 176
2025
Q2
$12K Hold
3,500
– – 0.01% 164
2025
Q1
$7.46K Hold
3,500
– – ﹤0.01% 195
2024
Q4
$11.2K Hold
3,500
– – 0.01% 173
2024
Q3
$46.7K Sell
3,500
-31,500
-90% -$419K 0.03% 92
2024
Q2
$37.4K Buy
35,000
+31,500
+900% +$455K 0.03% 92
2024
Q1
$41.6K Hold
3,500
– – 0.03% 81
2023
Q4
$14.1K Hold
3,500
– – 0.01% 115
2023
Q3
$9.6K Hold
3,500
– – 0.01% 127
2023
Q2
$23.4K Hold
3,500
– – 0.02% 95
2023
Q1
$22.3K Hold
3,500
– – 0.02% 97
2022
Q4
$8.65K Buy
+3,500
New +$11.5K 0.01% 140

Other funds holding CATX

JDM Financial Group's CATX Position: Q3 2026 in Review

JDM Financial Group held its Perspective Therapeutics (CATX) position steady in Q3 2026 at 3,500 shares worth $9.6K. The position accounts for ﹤0.01% of the portfolio, ranked #212.

JDM Financial Group first reported a position in CATX in Q4 2022 and has held it in 16 quarters since. The position peaked at $46.7K in Q3 2024. 120 funds tracked by Wall St. Rank hold CATX as of Q3 2026.

  • JDM Financial Group held 3,500 shares of Perspective Therapeutics worth $9.6K as of Q3 2026.
  • JDM Financial Group left its Perspective Therapeutics share count unchanged in Q3 2026.
  • Perspective Therapeutics made up ﹤0.01% of JDM Financial Group's portfolio in Q3 2026, its #212 holding.
  • JDM Financial Group first reported a position in Perspective Therapeutics in Q4 2022 and has held it in 16 quarters since.
  • JDM Financial Group's Perspective Therapeutics position peaked at $46.7K in Q3 2024.
  • 120 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2026.

Based on JDM Financial Group's 13F filing for Q3 2026, filed 17 Nov 2026.